Ajanta Pharma Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	9,204	8,162	5,880	7,127	6,539
Depreciation & Amortization	1,359	1,304	1,267	1,214	1,114
Other Amortization	82.2	50.1	41	39.4	46.9
Loss (Gain) From Sale of Assets	6	-34.9	61.9	38.7	22.1
Loss (Gain) From Sale of Investments	-113.1	-20.1	14.8	-52.3	51.9
Stock-Based Compensation	38.8	54.9	2.2	3	0.2
Other Operating Activities	-793.7	-667.1	-14.1	-748.2	76.8
Change in Accounts Receivable	804.8	-1,789	-105.5	-2,697	311.3
Change in Inventory	-745.1	-123	-223.7	-256.6	-2,715
Change in Accounts Payable	-84.5	408.5	969.1	-480.2	111.5
Change in Other Net Operating Assets	1,814	505.5	28.6	1,430	204.2
Operating Cash Flow	11,572	7,851	7,921	5,617	5,763
Operating Cash Flow Growth	47.41%	-0.89%	41.02%	-2.53%	26.17%
Capital Expenditures	-3,179	-1,524	-1,745	-1,488	-1,716
Sale of Property, Plant & Equipment	11.4	133.8	7.3	183.8	17.1
Investment in Securities	-1,040	1,776	-3,907	287.8	-1,255
Other Investing Activities	442.4	267.9	48.7	275.8	129.7
Investing Cash Flow	-3,765	653.9	-5,596	-741	-2,824
Long-Term Debt Issued	11	0.6	-	2.3	-
Total Debt Issued	11	0.6	-	2.3	-
Long-Term Debt Repaid	-114.6	-125.5	-112.3	-137.5	-626
Total Debt Repaid	-114.6	-125.5	-112.3	-137.5	-626
Net Debt Issued (Repaid)	-103.6	-124.9	-112.3	-135.2	-626
Issuance of Common Stock	0.1	-	-	-	-
Repurchase of Common Stock	-3,513	-3,883	-	-2,856	-1,354
Common Dividends Paid	-3,494	-6,422	-896.9	-822.1	-829
Other Financing Activities	-223.5	-81.3	-72.8	-783.9	-373.8
Financing Cash Flow	-7,334	-10,511	-1,082	-4,597	-3,183
Net Cash Flow	473	-2,006	1,243	279	-243.6
Free Cash Flow	8,393	6,327	6,176	4,129	4,047
Free Cash Flow Growth	32.66%	2.44%	49.59%	2.02%	86.20%
Free Cash Flow Margin	18.06%	15.03%	16.50%	12.36%	14.01%
Free Cash Flow Per Share	67.05	50.21	48.20	31.84	30.98
Cash Interest Paid	207.4	72.1	58.4	102	49.6
Cash Income Tax Paid	3,230	3,121	1,513	2,391	2,304
Levered Free Cash Flow	6,621	1,165	8,146	1,893	3,096
Unlevered Free Cash Flow	6,750	1,210	8,183	1,956	3,148
Change in Working Capital	1,789	-997.8	668.5	-2,004	-2,088

Source: S&P Global Market Intelligence. Standard template. Financial Sources.